COVID-19 antibody / German Center for Infection Research - LARVOL DELTA

Evaluation of a New Spike (S)-Protein-Based Commercial Immunoassay for the Detection of Anti-SARS-CoV-2 IgG. (PubMed, Microorganisms) - "Additionally, the Immundiagnostik assay correlated well with serum-neutralizing activity. The novel IDK anti-SARS-CoV-2 S1 IgG assay showed high sensitivity and specificity, representing a valid option for use in the routine diagnostic."

Journal • Infectious Disease • Novel Coronavirus Disease • Respiratory Diseases

German authorities approve third clinical trial of COVID-19 vaccine (Times Now) - "Germany's Federal Institute for Vaccines and Biomedicines, the Paul-Ehrlich-Institut (PEI), approved the third clinical trial of a potential COVID-19 vaccine on Friday. The vaccine candidate was developed by the German Center for Infection Research (DZIF) and the pharmaceutical company IDT Biologika. During the Phase-1 trial, 30 healthy adult volunteers between 18 and 55 years would receive two vaccinations at a four-week interval, according to PEI."

New P1 trial • Infectious Disease • Novel Coronavirus Disease